Larvol Delta - Evaluation-of-IGM6268-in-Healthy-Adults-and-Patients-With-Mild-to-Moderate-COVID19

IGM-6268 - Atreca, BeiGene, IGM Biosciences

http://clinicaltrials.gov/ct2/show/NCT05184218

Feb 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next